926 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Recruiting Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Surgery;   Radiation: SABR
8 Not yet recruiting Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
Condition: Non-small-cell Lung Cancer With Somatic EGFR Mutations
Interventions: Drug: Afatinib;   Drug: Pemetrexed
9 Not yet recruiting Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small -Cell Lung;   Ovarian Neoplasms;   Small Cell Lung Carcinoma;   Uterine Cervical Neoplasms;   Carcinoma, Neuroendocrine
Interventions: Drug: Topotecan;   Drug: VX-970
10 Recruiting Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab (MPDL3280A);   Other: Best Supportive Care (BSC)
11 Not yet recruiting Study Evaluating the Efficacy, Safety and Pharmacokinetics in Patient With T790M-positive Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: HM61713 tablet
12 Not yet recruiting Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
13 Not yet recruiting Efficacy Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Topotecan;   Drug: Amrubicin
14 Not yet recruiting Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
Condition: Non-small Cell Lung Cancer
Intervention: Procedure: segmentectomy
15 Not yet recruiting Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Bone Metastasis
Interventions: Drug: Zoledronic acid;   Radiation: Radiotherapy
16 Not yet recruiting MPDL3280A-treatment-IST-UMCG
Conditions: Bladder Cancer;   Non Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: MPDL3280A
17 Not yet recruiting An Open-Label, Trial of Nivolumab and Nivolumab Plus Ipilimumab Versus Platinum Doublet Chemotherapy in Subjects With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Pemetrexed
18 Recruiting Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
Condition: Small Cell Lung Cancer Recurrent
Intervention: Drug: Temozolomide
19 Not yet recruiting Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
20 Available Expanded Access Program With Nivolumab Monotherapy for Treatment of Advanced/Metastatic SqNSCLC After One Prior Systemic Regimen
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Nivolumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years